Meeting: EHA | DocGuide

Auto-generated: May 16 2012 01:43 PM GMT-8

Meeting: EHA

73

Stars

Source: DGNews | Posted 1 year ago

Lenalidomide Plus Dexamethasone Benefits Patients With Relapsed/Refractory Multiple Myeloma

Tags:

Read/Add Comments

62

Stars

Source: DGNews | Posted 1 year ago

Nilotinib Improves Response Rate in Patients With CML in Blast Crisis

Tags:

Read/Add Comments

32

Stars

Source: DGNews | Posted 1 year ago

Addition of Alemtuzumab to Fludarabine Improves Progression-Free Survival in Patients With Chronic Lymphocytic Leukaemia

Tags:

Read/Add Comments

70

Stars

Source: DGNews | Posted 1 year ago

Genetic Variations Influence Patient Response to Treatment for Multiple Myeloma

Tags:

Read/Add Comments

43

Stars

Source: DGNews | Posted 1 year ago

Lenalidomide-Based Triple Therapy Prolongs Progression-Free Survival in Elders With Multiple Myeloma

Tags:

Read/Add Comments

38

Stars

Source: DGNews | Posted 1 year ago

Nilotinib Continues to Be Superior to Imatinib at 15 Months in Chronic Myeloid Leukaemia

Tags:

Read/Add Comments

32

Stars

Source: DGNews | Posted 1 year ago

Triple-Combination Therapy Prolongs Progression-Free Survival in Elderly Patients With Multiple Myeloma

Tags:

Read/Add Comments

68

Stars

Source: DGNews | Posted 1 year ago

Dabigatran Controls Bleeding Events Following Primary Total Hip Arthroplasty

Tags:

Read/Add Comments

50

Stars

Source: DGNews | Posted 1 year ago

Lenalidomide Provides Increased Response, Survival Rates in Elderly Patients With Multiple Myeloma

Tags:

Read/Add Comments

39

Stars

Source: DGNews | Posted 1 year ago

All-Trans Retinoic Acid Plus Arsenic Trioxide Shows Promise for Acute Promyelocytic Leukaemia

Tags:

Read/Add Comments

Terms of Use | Privacy Policy

© All Content Copyright 1995 - 2012 Doctor's Guide Publishing Limited. All Rights Reserved.